Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Web Resources
|
![]() |
Zolmax.com - American Consumer News: Aecon Group Inc. (TSE:ARE) Receives C$13.89 Average Price Target from AnalystsNewstex Global Business Blogs, 2023Copyright Newstex Aug 10, 2023Digital Resources/Online E-Resources |
2 |
Material Type: Web Resources
|
![]() |
Zacks Investment Research: Wall Street Analysts Believe Skillsoft (SKIL) Could Rally 392.72%: Here's is How to TradeNewstex Finance & Accounting Blogs, 2024Copyright Newstex Apr 16, 2024Digital Resources/Online E-Resources |
3 |
Material Type: Web Resources
|
![]() |
Zacks Investment Research: Wall Street Analysts See a 95.06% Upside in SIGMA LITHIUM (SGML): Can the Stock Really Move This High?Newstex Finance & Accounting Blogs, 2024Copyright Newstex Apr 16, 2024Digital Resources/Online E-Resources |
4 |
Material Type: Web Resources
|
![]() |
Zacks Investment Research: Wall Street Analysts Believe NextEra Energy Partners (NEP) Could Rally 29.04%: Here's is How to TradeNewstex Finance & Accounting Blogs, 2024Copyright Newstex Apr 16, 2024Digital Resources/Online E-Resources |
5 |
Material Type: Web Resources
|
![]() |
Zacks Investment Research: Wall Street Analysts Believe Bank7 (BSVN) Could Rally 25.48%: Here's is How to TradeNewstex Finance & Accounting Blogs, 2024Copyright Newstex Apr 16, 2024Digital Resources/Online E-Resources |
6 |
Material Type: Web Resources
|
![]() |
Zacks Investment Research: Wall Street Analysts Think Adma Biologics (ADMA) Could Surge 33.56%: Read This Before Placing a BetNewstex Finance & Accounting Blogs, 2024Copyright Newstex Mar 18, 2024Digital Resources/Online E-Resources |
7 |
Material Type: Web Resources
|
![]() |
Zacks Investment Research: Wall Street Analysts Think Protagonist Therapeutics (PTGX) Could Surge 48.38%: Read This Before Placing a BetNewstex Finance & Accounting Blogs, 2024Copyright Newstex Mar 18, 2024Digital Resources/Online E-Resources |
8 |
Material Type: Web Resources
|
![]() |
Zacks Investment Research: Wall Street Analysts See a 54.78% Upside in Arcutis Biotherapeutics, Inc. (ARQT): Can the Stock Really Move This High?Newstex Finance & Accounting Blogs, 2024Copyright Newstex Mar 18, 2024Digital Resources/Online E-Resources |
9 |
Material Type: Web Resources
|
![]() |
Zacks Investment Research: Does Inovio (INO) Have the Potential to Rally 122.92% as Wall Street Analysts Expect?Newstex Finance & Accounting Blogs, 2024Copyright Newstex Mar 8, 2024Digital Resources/Online E-Resources |
10 |
Material Type: Web Resources
|
![]() |
Zacks Investment Research: Does Primis Financial (FRST) Have the Potential to Rally 27.63% as Wall Street Analysts Expect?Newstex Finance & Accounting Blogs, 2024Copyright Newstex Mar 8, 2024Digital Resources/Online E-Resources |
11 |
Material Type: Web Resources
|
![]() |
Zacks Investment Research: Can Exact Sciences (EXAS) Climb 55.43% to Reach the Level Wall Street Analysts Expect?Newstex Finance & Accounting Blogs, 2024Copyright Newstex Mar 8, 2024Digital Resources/Online E-Resources |
12 |
Material Type: Web Resources
|
![]() |
Zacks Investment Research: Wall Street Analysts Believe Full Truck Alliance Co. Ltd. Sponsored ADR (YMM) Could Rally 62.83%: Here's is How to TradeNewstex Finance & Accounting Blogs, 2024Copyright Newstex Mar 8, 2024Digital Resources/Online E-Resources |
13 |
Material Type: Web Resources
|
![]() |
Zacks Investment Research: Wall Street Analysts Think Anterix (ATEX) Could Surge 64.49%: Read This Before Placing a BetNewstex Finance & Accounting Blogs, 2024Copyright Newstex Mar 8, 2024Digital Resources/Online E-Resources |
14 |
Material Type: Web Resources
|
![]() |
Zacks Investment Research: Wall Street Analysts Think TransAlta (TAC) Could Surge 72.17%: Read This Before Placing a BetNewstex Finance & Accounting Blogs, 2024Copyright Newstex Mar 8, 2024Digital Resources/Online E-Resources |
15 |
Material Type: Web Resources
|
![]() |
Zacks Investment Research: Wall Street Analysts Think Brookfield Infrastructure (BIP) Could Surge 25.85%: Read This Before Placing a BetNewstex Finance & Accounting Blogs, 2024Copyright Newstex Feb 8, 2024Digital Resources/Online E-Resources |
16 |
Material Type: Web Resources
|
![]() |
Zacks Investment Research: Wall Street Analysts Predict a 108.12% Upside in Enanta Pharmaceuticals (ENTA): Here's What You Should KnowNewstex Finance & Accounting Blogs, 2023Copyright Newstex Dec 13, 2023Digital Resources/Online E-Resources |
17 |
Material Type: Web Resources
|
![]() |
Zacks Investment Research: How Much Upside is Left in Immunocore Holdings PLC Sponsored ADR (IMCR)? Wall Street Analysts Think 30.32Newstex Finance & Accounting Blogs, 2023Copyright Newstex Dec 13, 2023Digital Resources/Online E-Resources |
18 |
Material Type: Web Resources
|
![]() |
Zacks Investment Research: Wall Street Analysts Believe MediWound (MDWD) Could Rally 171.79%: Here's is How to TradeNewstex Finance & Accounting Blogs, 2023Copyright Newstex Dec 13, 2023Digital Resources/Online E-Resources |
19 |
Material Type: Web Resources
|
![]() |
Zacks Investment Research: Wall Street Analysts Predict a 149.52% Upside in Fusion Pharmaceuticals Inc. (FUSN): Here's What You Should KnowNewstex Finance & Accounting Blogs, 2023Copyright Newstex Dec 13, 2023Digital Resources/Online E-Resources |
20 |
Material Type: Web Resources
|
![]() |
Zacks Investment Research: Does Smartsheet (SMAR) Have the Potential to Rally 25.16% as Wall Street Analysts Expect?Newstex Finance & Accounting Blogs, 2023Copyright Newstex Dec 13, 2023Digital Resources/Online E-Resources |